SPDR Biotech (XBI) corporate_fare

Buy indicator:           [ What are these indicators? ]
Profit target:       [ A higher % profit will take longer and is less likely to be achieved ]

Key: arrow_drop_up : profitable trade arrow_drop_up : breakeven trade (minimal loss after 2 years) arrow_drop_up : losing trade (not profitable in a 2 year timeframe)
*Transaction costs, taxes and dividends are excluded from these calculations. Past performance may not necessarily be a reliable guide to future performance.

 

52 Week Low Backtest Summary

This table summarises how profitable it would have been to have bought this stock at each 52 week low entry signal. Hover over the icons to see more details of the particular trade, including the maximum percentage drawdown and how long it took to reach the desired percentage profit.

Key:   disabled_by_default = profit point not achieved. select_check_box = profit point achieved with CAGR above 15%.
select_check_box = profit point achieved with CAGR of between 5% and 15%. select_check_box = profit point achieved but CAGR was less than 5%.

Signal Date Price Performance (mouseover for details)
5% 10% 20%
31 March 2025 $81.30 select_check_box disabled_by_default disabled_by_default
27 October 2023 $65.26 select_check_box select_check_box select_check_box
21 September 2023 $73.66 select_check_box select_check_box select_check_box
22 April 2022 $80.30 select_check_box select_check_box select_check_box
23 February 2022 $86.98 select_check_box select_check_box select_check_box
18 January 2022 $96.66 disabled_by_default disabled_by_default disabled_by_default

 

The data for SPDR Biotech (exchange: ARCX symbol: XBI) was last updated 28 Sep 2025 13:18. Data for this ETF is available from 04 Jan 2021 - 26 Sep 2025.